Fabtech TechnologiesNSE:FABTECH +2.76%31 Current Ratio is 2.52 as of Mar. 2026, which is 70% above its 10-year median of 1.48. GuruFocus rates NSE:FABTECH with a GF Score™ of 31/100. The stock has 4 warning signs investors should review. Among 678 Healthcare Providers & Services companies, Fabtech Technologies ranks better than 73.01% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Fabtech Technologies's current ratio for the quarter that ended in Mar. 2026 was 2.52.
Fabtech Technologies has a current ratio of 2.52. It generally indicates good short-term financial strength.
The historical rank and industry rank for Fabtech Technologies's Current Ratio or its related term are showing as below:
NSE:FABTECH'
s Current Ratio Range Over the Past 10 Years
Min: 1.39 Med: 1.48 Max: 2.52
Current: 2.52
During the past 5 years, Fabtech Technologies's highest Current Ratio was 2.52. The lowest was 1.39. And the median was 1.48.
NSE:FABTECH's Current Ratio is ranked better than 73.01% of 678
companies
in the Healthcare Providers & Services industry
Industry Median: 1.48
vs NSE:FABTECH: 2.52
Fabtech Technologies (NSE:FABTECH) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Fabtech Technologies Current Ratio Related Terms
Fabtech Technologies Current Ratio Historical Data
* Premium members only.
The historical data trend for Fabtech Technologies's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:FABTECH vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, Fabtech Technologies's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabtech Technologies Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fabtech Technologies's Current Ratio distribution charts can be found below:
* The bar in red indicates where Fabtech Technologies's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabtech Technologies (NSE:FABTECH) has a Current Ratio of 2.52 as of Mar. 2026. This is 70% above median its historical median of 1.48. Over the past decade, Fabtech Technologies' Current Ratio has ranged from 1.39 to 2.52. According to the industry distribution chart, Fabtech Technologies ranks #183 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 27%.
Is Fabtech Technologies' Current Ratio too high?
Fabtech Technologies' current Current Ratio of 2.52 is 70% above median its 10-year median of 1.48. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 2.52. The Healthcare Providers & Services industry median Current Ratio is 1.48. Fabtech Technologies' value of 2.52 is 70.3% above this industry median. Based on the distribution chart, Fabtech Technologies ranks #183 out of 678 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fabtech Technologies has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Fabtech Technologies' Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Fabtech Technologies ranks #183 out of 678 companies for Current Ratio. This puts Fabtech Technologies in the upper half of its industry. The industry median Current Ratio is 1.48. Fabtech Technologies' value of 2.52 is 70.3% above this benchmark. Historically, Fabtech Technologies' own Current Ratio has ranged from 1.39 to 2.52 over the past decade. While the company's 10-year median is 1.48 vs. the industry median of 1.48, Fabtech Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.48, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabtech Technologies's current Current Ratio of 2.52 is 70.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabtech Technologies's current Current Ratio is 2.52, which is 70% above median its own 10-year median of 1.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabtech Technologies stock overvalued right now?
Fabtech Technologies (NSE:FABTECH) has a current Current Ratio of 2.52. The current Current Ratio is 2.52, which is 70% above median its 10-year median of 1.48 and 70.3% above the Healthcare Providers & Services industry median of 1.48. Fabtech Technologies' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Fabtech Technologies (NSE:FABTECH), the current Current Ratio is 2.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fabtech Technologies Ltd is engaged in building pharmaceutical, biotech, and healthcare capabilities for a wide range of customers by offering comprehensive start-to-finish turnkey solutions, which include supplying pharmaceutical machinery/equipment, in-house designing and engineering, procurement, installation, validation, and undertaking other activities required in various projects, including standalone equipment supply and installation. The company provides solutions for clean air, manufacturing processes, purified water and pure steam generation and distribution, etc. The majority of its revenue is generated from the trading of pharmaceutical and surgical products. Geographically, the company derives maximum revenue from international markets, and the rest from its business in India.
31GF Score
Get the complete analysis for NSE:FABTECH
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:FABTECH has been successfully added to your 